Jefferies Upgrades PTC Therapeutics (PTCT) to Buy, 'deep dive suggests Sephience should continue to beat expectations'
Tweet Send to a Friend
(Updated - May 27, 2026 8:52 AM EDT)
Jefferies analyst Faisal Khurshid upgraded PTC Therapeutics (NASDAQ: PTCT) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Faisal Khurshid upgraded PTC Therapeutics (NASDAQ: PTCT) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
